53. Support POC EID as well as case-finding through enhanced testing in inpatient, TB, and nutrition wards.
54. Promote family HIV testing as a strategy for identifying children with HIV.
55. Provide additional investments and support in West and Central Africa through Bridge to Scale POC diagnostics (including optimizing multiplexing) to close the diagnostic and paediatric ART treatment gaps.
UNICEF and CHAI are supporting the transitioning of the initial UNITAID supported POC countries (Malawi, Mozambique, Uganda, Kenya, Ethiopia, Tanzania, Senegal, DRC, Cameroun, Zimbabwe) to other sources of funding for strategic scale up of efforts.
In collaboration with WHO, UNAIDS and partners, UNICEF is supporting the national roll-out of Family Index Case Testing in WCA (focus countries: Burkina Faso, Cameroon, CAR, Chad, CDI, DRC, Equatorial Guinea, Ghana, Nigeria) within the context of regional catch up plans to close the paediatric testing gap. As part of this support UNICEF has developed operational guidance on Family Testing and a draft toolkit. UNICEF is also providing direct country technical assistance within the region, including for global fund reprogramming to align investments with paediatric testing and treatment needs.
UNICEF is supporting the expansion of POC through an innovations to scale POC project in 10 countries (Burkina Faso, Cape Verde, CAR, Chad, Congo, Equatorial Guinea, Gabon, Ghana, Mali, Nigeria) beginning this quarter with landscape analysis in 3 countries (Mali, Chad, Ghana) and laboratory systems strengthening training of technical teams from the countries. This project builds on the earlier POC UNITAID project lessons and experiences that are harnessed and shared through a collaborative POC community of practice.
68. Expand the demand for optimal paediatric ARVs in Western and Central Africa, increasing coverage of ART from 24% to 30% by adding 3,000 children on treatment by end of 2021 through enhanced case identification of children and expanded provider capacity.
69. Through dialogue and negotiation with manufacturers to implement flat pricing for pediatric drugs and to issue voluntary licenses or commitment to non-enforcement of patents with respect to pediatric ARVs.
70. Support national governments to implement targeted and differentiated services deliveries for children and adolescents anchored in continuous quality improvement through the rollout of the service delivery framework.
27. UNICEF commits to collaborate with GAP-f partners to develop, test, and disseminate training tools for treatment initiation with LPV/r and other optimal pediatric formulations
49. Support Ministries of Health to expand paediatric care and treatment within broader MCH services
• UNICEF continues to engage with the paediatric ARV working group and PADO - led by WHO and partners, to ensure targeted and rapid development of priority commodities for pediatric HIV, and has supported the creation and utilization of practical guidance to promote uptake
• UNICEF has participated in the rollout of new WHO guidelines for HIV testing and treatment in children through a number of fora including within national pediatric HIV technical working groups and at regional meetings such as the HLM in Dakar, Senegal
• UNICEF continues to advocate and define models for scaling up high quality pediatric treatment through effective and supported integration within MCH
- Working with UNAIDS on improving data disaggregation for children and adolescents
- working with UNAIDS on analysis to see impact of PMTCT on estimates of children living with HIV
- plan to convene a meeting of all partners working on implementation to help countries optimize service delivery for children
Action 25. Work with countries on creating demand for paediatric HIV treatment services including generation of age disaggregated data to inform the better planning and supply forecasting.
Action 26. Through UNICEF supply Division, support rapid country adoption of new recommended regimens by including them on the UNICEF procurement services product lists and tenders for long term agreements.
128. Support countries to collect and report data on TB-HIV co-infection and TB treatment initiation and outcomes in children living with HIV.
129. Advocate for increased pediatric TB case-finding and access to child-friendly treatment as a core member of the TB Child and Adolescent Working Group and the TB PADO.
130. Support national governments to optimize the integration of TB with child health, HIV, and nutrition services.